METRO MINNESOTA COMMUNITY CLINICAL ONCOLOGY PROGRAM

明尼苏达都会区社区临床肿瘤学计划

• 批准号: 2894579
• 负责人: PATRICK J FLYNN
• 金额: $ 88.19万
• 依托单位: PARK NICOLLET INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2000-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2894579
• 关键词: behavioral /social science research tag; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; clinical trials; community health services; continuing education; cooperative study; health care referral /consultation; hospitals; human subject; human therapy evaluation; managed care; medical outreach /case finding; medical rehabilitation related tag; neoplasm /cancer education; neoplasm /cancer therapy; patient /disease registry; pharmacy administration; primary care physician; prostate neoplasms

The Metro-Minnesota Community Clinical Oncology Program (MMCCOP) represents a consortium of eight hospitals which, through its NCI-funded Community Hospital Oncology Program ("CHOP") and operational CCOP, has already developed a common approach to the management of cancer patients and has an established mechanism for entering and following patients on treatment and cancer control protocols. The consortium has a community- wide computerized data management system capable of prospective data collection. The community offers 5 HMO programs, all of which are represented among these eight consortium hospitals. Together, the eight hospitals see an average of 7500 new analytic cancer patients per year. The sixty-seven core investigators, representing oncology, hematology, radiation oncology, urology, gynecologic oncology, neurology, ENT, and colorectal surgery, have worked extensively together on cancer program development and protocol management. The MMCCOP staff is qualified and trained in oncology and data management, and has been involved in the development of the current program structure and operation. During the most recent NCI-funded grant year (6/93-5/94), the MMCCOP entered 318 patients (144.7 treatment credits/86 cancer control credits) onto NCI- approved studies. An additional 64 men were enrolled in the Prostate Cancer Prevention Trial and were pending credit (not allowed until after completion of 3 month run-in period). The MMCCOP intends to sustain a region wide community and hospital consortium which provides the community with the most recent advances in cancer control and treatment. This will be accomplished through expansion of the CCOP into established outreach communities; work with hospitals, foundations, insurers and Integrated Service Networks (ISNs) to develop funding and reimbursement support for participation in clinical trials; increased involvement of primary care physicians; providing the expertise, resources, and large population base to develop, implement and evaluate clinical cancer treatment and control trials through affiliation with the NCI, ECOG, M.D. Anderson, NSABP, URCC, and RTOG; improve and expand the current MMCCOP data management and communication system to increase the number add level of participation of the investigators in accrual, program operations and research base activities; identify and recruit key investigators to access minority group participation; and increase the professional and lay community awareness of the CCOP and benefits of clinical cancer trials. Based upon past experience and improved cancer control implementation models, MMCCOP investigators intend to accrue 350 credits onto NCI-approved cancer treatment and control studies during the first year, exceeding the minimum requirements for both types of studies.

大都会-明尼苏达州社区临床肿瘤学计划(MMCCOP) 代表一个由八家医院组成的财团，通过其NCI资助的 社区医院肿瘤学计划(CHOP)和运营CCOP，有 已经开发出一种管理癌症患者的通用方法 并有一套既定的进入和跟踪患者的机制 治疗和癌症控制方案。该财团有一个社区- 可预测数据的广域计算机化数据管理系统 收集。该社区提供了5个HMO计划，所有这些计划都是 在这八家联盟医院中有代表。一起，八人组 医院平均每年新增7500名癌症分析患者。 67名核心调查人员，代表肿瘤学、血液学、 放射肿瘤学、泌尿科、妇科肿瘤学、神经病学、耳鼻喉科和 结直肠手术，在癌症项目上广泛合作 开发和协议管理。MMCCOP的工作人员是合格的和 接受过肿瘤学和数据管理方面的培训，并参与了 发展现行方案的结构和运作。在.期间 最近一次NCI资助的赠款年度(9/93-5/94)，MMCCOP进入318 患者(144.7个治疗学分/86个癌症控制学分)进入美国国立卫生研究院- 已获批准的研究。另一名男子被录取到前列腺癌 癌症预防试验，正在等待积分(在此之后才被允许 完成3个月的磨合期)。MMCCOP打算维持一个 全区社区和医院联合体，提供 社区在癌症控制和治疗方面的最新进展。 这将通过将CCOP扩展为已建立的 外展社区；与医院、基金会、保险公司和 综合服务网络(ISNS)以开发资金和报销 支持参与临床试验；更多地参与 初级保健医生；提供专业知识、资源和大量 制定、实施和评估临床癌症的人口基础 通过与NCI、ECOG、M.D.合作进行的治疗和对照试验。 Anderson、NSABP、URCC和RTOG；改进和扩展当前的MMCCOP 增加数据管理和通信系统的数量增加水平 调查员参与权责发生、方案运作和 研究基地活动；确定和招募关键调查人员以 获得少数群体的参与；并增加专业和 提高社区对CCOP和临床癌症益处的认识 审判。基于过去的经验和改进的癌症控制 实施模式，MMCCOP调查人员打算累积350个学分 NCI批准的癌症治疗和控制研究在第一次 一年，超过了这两种学习的最低要求。